MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
MCM3 上调导致乳腺癌产生内分泌抵抗,并且是他莫昔芬疗效减弱的预测标志
期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-020-00210-8
Sanne Løkkegaard, Daniel Elias, Carla L Alves, Martin V Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F Gjerstorff, Lene E Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S Lindström, Laura J Esserman, Anne E Lykkesfeldt, Jens S